2022 MLS San Francisco | Biosimilars Implementation in the US: A Five Year Review

2022 MLS San Francisco | Biosimilars Implementation in the US: A Five Year Review

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Date of Release

May 14th, 2025